Kolon Life Science Inc. (KOSDAQ:102940)

Kolon Life Science Revenue

Kolon Life Science had revenue of 50.59B KRW in the quarter ending June 30, 2026, a decrease of -4.47%. This brings the company's total for the last twelve months to 211.44B, up 17.09% year-over-year. In the year 2025, Kolon Life Science had annual revenue of 208.98B with 29.49% growth. That makes Kolon Life Science the 19,196th largest company in the world by revenue and 998th in South Korea.

• Revenue (ttm): 211.44B
• Revenue Growth: +17.09%
• P/S Ratio: 0.75
• Revenue / Employee: 480.54M
• Employees: 440
• Market Cap: 158.92B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Chemical Business Division 205.13B 98.2%
• Bio Business Division 3.85B 1.8%

By Geography

Chart

• Korea 82.00B 39.2%
• Japan 65.96B 31.6%
• Asia/Pacific 43.20B 20.7%
• Other 11.86B 5.7%
• Europe 5.95B 2.8%

Fiscal year ended Dec 31, 2025 See the full Kolon Life Science breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	208.98B	47.59B	29.49%
Dec 31, 2024	161.39B	36.75B	29.48%
Dec 31, 2023	124.64B	-36.94B	-22.86%
Dec 31, 2022	161.58B	-3.90B	-2.36%
Dec 31, 2021	165.49B	36.07B	27.87%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error